课题基金基金详情
中草酸钙尿石患者尿凝血酶原F1分子异常及其机制研究
结题报告
批准号:
39970740
项目类别:
面上项目
资助金额:
11.0 万元
负责人:
刘继红
依托单位:
学科分类:
H0508.泌尿系结石与感染
结题年份:
2002
批准年份:
1999
项目状态:
已结题
项目参与者:
叶章群、章咏裳、王少刚、尹春萍、庄乾元、李浩勇、梁培育、郭小林、邓荣进
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
有研究显示某些尿蛋白分异常与尿石形成有关。本研究拟先通过鉴定草酸钙尿石患者尿凝血酶原片段落(UPTF1)分子特征及抑制草酸钙晶体生长和聚集的活性变化以了解UPTF1分子异常情况;再研究凝血酶原基因突变和UPTF1分子中谷氨酸的羧基化机制以探讨UPTF1分子异常折机制。这有助于阐明尿石症发病机制、为尿石症的基因诊断及临床治疗提供理论依据。.
英文摘要
Urinary prothrombin fragment 1(UPTF1)is an important component of calcium oxalate crystal surface binding proteins(CSBP). It was manifested there was the correlation between UPTF1 and urolithiasis in vitro, but the role of UPTF1 on urolithiasis in vivo is ambiguous. Using DEAE-Sepharose CL-6B to isolate prothrombin, and using a seeded crystallization technique, it was observed that CSBP and UPTF1 of normal subjects could apparently inhibit calcium oxalate crystal growth. CSBP of stone former showed lower inhibitory activity than that of normal subjects. Using enzyme-linked immunoadsordent assay, it was observed that the combining ability with calcium oxalate crystal of UPTF1 in calcium oxalate stone formers was significantly weaker than that in normal subjects. When protein-bound Gla was determined in the crystal matrix and urine of normal subjects and calcium oxalate stone formers by high performance liquid chromatography, it was found that protein-bound Gla in the crystal matrix and urine of normal subjects and calcium oxalate stone formers were significantly less than that of normal subjects. it was concluded that fully carboxylated Gla-bound proteins are inhibitory factors of calcium oxalate calculus. Using reverse transcriptase-polymerase chain reaction and immunohistochemical techniques, UPTF1 was visible as cytoplasmic staining in the epithelial cells of the TALH and the distal convoluted tubule and kidney tissue showed clear evidence of prothrombin mRNA expression, it is concluded that UPTF1 is synthesized and excreted in kidney. When the activity of carboxylase was detected by carboxylation reaction in vitro(calcium oxalate stone formers and mice) , it was observed that the activity of vitamin K dependent carboxylase was higher in the group of experimental urolithiasis in kidney, it was verified that the vitamin K dependent carboxylase may play a role in the pathology of urolithiasis. When the gene mutations were determined by single conformation polymorphism(SSCP) and DNA sequencing, gene mutations was not observed ofγ- carboxyglutamic acid domain of prothrombin in patients with calcium oxalate calculus, it was verified that the formation of calcium oxalate calculus is not related to the genetic mutation of γ- carboxyglutamic acid domain of prothrombin. It was found that the carboxylation defection of UPTF1 play an important role in the pathologenesis of calcium oxalate calculus, and the activity reduction of vitamin K dependent carboxylase result in carboxylation defection of UPTF1. It provided a theory foundation to explore pathogenesis of calcium oxalate calculus for next step. Our investigation on UPTF1 belongs to the part of research on CSBP, and represents the latest research direction, and establishes a new pathway for the research on etiological factor of urolithiasis in our country.
专著列表
科研奖励列表
会议论文列表
专利列表
SpCas9-NG-ES移码突变MBD2在糖尿病ED发病和治疗中的作用及其机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    刘继红
  • 依托单位:
良性前列腺增生铥激光微创手术机器人基础理论和关键技术研究
  • 批准号:
    92048204
  • 项目类别:
    重大研究计划
  • 资助金额:
    240万元
  • 批准年份:
    2020
  • 负责人:
    刘继红
  • 依托单位:
平滑肌外泌体介导CRISPRi技术调控PDE5和JAK2基因治疗糖尿病ED的实验研究
  • 批准号:
    81873831
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘继红
  • 依托单位:
SEMA4D基因突变在孤立性促性腺激素释放激素缺乏症发病中的作用及机制研究
  • 批准号:
    81671443
  • 项目类别:
    面上项目
  • 资助金额:
    61.0万元
  • 批准年份:
    2016
  • 负责人:
    刘继红
  • 依托单位:
利用条件性基因敲除小鼠模型研究JAK2激酶在糖尿病ED中的作用及机制
  • 批准号:
    81471451
  • 项目类别:
    面上项目
  • 资助金额:
    74.0万元
  • 批准年份:
    2014
  • 负责人:
    刘继红
  • 依托单位:
利用转基因大鼠模型研究人组织激肽释放酶1对阴茎勃起功能的影响及作用机制
  • 批准号:
    81270690
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2012
  • 负责人:
    刘继红
  • 依托单位:
PDE5和iNOS基因修饰的自体脂肪干细胞移植治疗勃起功能障碍
  • 批准号:
    81070484
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2010
  • 负责人:
    刘继红
  • 依托单位:
RNA激活技术治疗勃起功能障碍的实验研究
  • 批准号:
    30872574
  • 项目类别:
    面上项目
  • 资助金额:
    34.0万元
  • 批准年份:
    2008
  • 负责人:
    刘继红
  • 依托单位:
siRNA抑制阴茎海绵体平滑肌细胞PDE5基因表达治疗ED的研究
  • 批准号:
    30471736
  • 项目类别:
    面上项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2004
  • 负责人:
    刘继红
  • 依托单位:
中药泽泻抑制尿草酸钙结石形成机理及其活性成分的研究
  • 批准号:
    39970891
  • 项目类别:
    面上项目
  • 资助金额:
    12.0万元
  • 批准年份:
    1999
  • 负责人:
    刘继红
  • 依托单位:
国内基金
海外基金